19491896	207	Shoji K	The oncogenic mutation in the pleckstrin homology domain of AKT1 in endometrial carcinomas.	British journal of cancer	2009	51
21788564	207	Oza AM	Phase II study of temsirolimus in women with recurrent or metastatic endometrial cancer: a trial of the NCIC Clinical Trials Group.	Journal of clinical oncology 	2011	55
12237281	672	Thompson D	Cancer Incidence in BRCA1 mutation carriers.	Journal of the National Cancer Institute	2002	206
23104009	1108	Le Gallo M	Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes.	Nature genetics	2012	108
23359684	1108	Zhao S	Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma.	Proceedings of the National Academy of Sciences of the United States of America	2013	64
23738515	1287	Mehine M	Characterization of uterine leiomyomas by whole-genome sequencing.	The New England journal of medicine	2013	38
19078924	1499	Bansal N	The molecular biology of endometrial cancers and the implications for pathogenesis, classification, and targeted therapies.	Cancer control 	2009	64
22653804	1499	McConechy MK	Use of mutation profiles to refine the classification of endometrial carcinomas.	The Journal of pathology	2012	45
23636398	1499	Cancer Genome Atlas Research Network.	Integrated genomic characterization of endometrial carcinoma.	Nature	2013	552
23765252	1499	McConechy MK	Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles.	Modern pathology 	2014	25
25720322	1499	Stelloo E	Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative.	Modern pathology 	2015	16
24656976	1956	Yan M	HER2 aberrations in cancer: implications for therapy.	Cancer treatment reviews	2014	40
24390348	1999	Ojesina AI	Landscape of genomic alterations in cervical carcinomas.	Nature	2014	113
10471491	2261	Cappellen D	Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas.	Nature genetics	1999	156
11865300	2271	Tomlinson IP	Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer.	Nature genetics	2002	253
12772087	2271	Toro JR	Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America.	American journal of human genetics	2003	93
14634372	2271	Linehan WM	The genetic basis of cancer of the kidney.	The Journal of urology	2003	94
16892079	2271	Brandon M	Mitochondrial mutations in cancer.	Oncogene	2006	190
16885385	2956	Hampel H	Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients.	Cancer research	2006	102
17003396	2956	Chen S	Prediction of germline mutations and cancer risk in the Lynch syndrome.	JAMA	2006	86
17327285	2956	Vasen HF	Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer).	Journal of medical genetics	2007	103
19622357	2956	Stoffel E	Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome.	Gastroenterology	2009	77
20028993	2956	Baglietto L	Risks of Lynch syndrome cancers for MSH6 mutation carriers.	Journal of the National Cancer Institute	2010	73
21642682	2956	Bonadona V	Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.	JAMA	2011	114
24323032	2956	Buchanan DD	Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing.	Journal of clinical oncology 	2014	24
24844595	2956	Meng B	POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium.	Gynecologic oncology	2014	22
25194673	2956	Haraldsdottir S	Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations.	Gastroenterology	2014	35
26657901	2956	Møller P	Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database.	Gut	2017	10
15572290	3251	DeMarini DM	Genotoxicity of tobacco smoke and tobacco smoke condensate: a review.	Mutation research	2004	95
25224212	4292	Billingsley CC	Polymerase ɛ (POLE) mutations in endometrial cancer: clinical outcomes and implications for Lynch syndrome testing.	Cancer	2015	17
19261849	5290	Salvesen HB	Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation.	Proceedings of the National Academy of Sciences of the United States of America	2009	83
19349352	5290	Kuo KT	Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma.	The American journal of pathology	2009	89
21266528	5290	Rudd ML	A unique spectrum of somatic PIK3CA (p110alpha) mutations within primary endometrial carcinomas.	Clinical cancer research 	2011	71
21829508	5290	Janku F	PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers.	PloS one	2011	60
22271473	5290	Janku F	PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations.	Journal of clinical oncology 	2012	145
22923510	5290	Kuhn E	Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses.	Journal of the National Cancer Institute	2012	58
9307275	5728	Tashiro H	Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies.	Cancer research	1997	127
10564676	5728	Ali IU	Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity.	Journal of the National Cancer Institute	1999	113
22252256	5728	Tan MH	Lifetime cancer risks in individuals with germline PTEN mutations.	Clinical cancer research 	2012	93
23335809	5728	Bubien V	High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome.	Journal of medical genetics	2013	30
24136893	5728	Pilarski R	Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria.	Journal of the National Cancer Institute	2013	41
1316611	5925	Chellappan S	Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product.	Proceedings of the National Academy of Sciences of the United States of America	1992	172
1648218	5925	Scheffner M	The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines.	Proceedings of the National Academy of Sciences of the United States of America	1991	178
23925245	6347	Adey A	The haplotype-resolved genome and epigenome of the aneuploid HeLa cancer cell line.	Nature	2013	73
19340305	6794	Wingo SN	Somatic LKB1 mutations promote cervical cancer progression.	PloS one	2009	80
9607760	7157	Storey A	Role of a p53 polymorphism in the development of human papillomavirus-associated cancer.	Nature	1998	122
12649205	7157	Pihan GA	Centrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas.	Cancer research	2003	102
20942669	8289	Wiegand KC	ARID1A mutations in endometriosis-associated ovarian carcinomas.	The New England journal of medicine	2010	322
21868628	9968	Mäkinen N	MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas.	Science	2011	112
22223266	9968	Markowski DN	MED12 mutations in uterine fibroids--their relationship to cytogenetic subgroups.	International journal of cancer	2012	33
22428002	9968	McGuire MM	Whole exome sequencing in a random sample of North American women with leiomyomas identifies MED12 mutations in majority of uterine leiomyomas.	PloS one	2012	35
25038752	9968	Lim WK	Exome sequencing identifies highly recurrent MED12 somatic mutations in breast fibroadenoma.	Nature genetics	2014	27
23696246	10460	Katoh M	FGF receptors: cancer biology and therapeutics.	Medicinal research reviews	2014	68
21882293	23405	Foulkes WD	Extending the phenotypes associated with DICER1 mutations.	Human mutation	2011	37
26181000	29126	Howitt BE	Association of Polymerase e-Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1.	JAMA oncology	2015	35
16462743	199713	Murdoch S	Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans.	Nature genetics	2006	77
18772439	221895	Li H	A neoplastic gene fusion mimics trans-splicing of RNAs in normal human cells.	Science	2008	94
23482656	100507436	Chen D	Genome-wide association study of susceptibility loci for cervical cancer.	Journal of the National Cancer Institute	2013	29
